Home » Topics » BioWorld Science, Endocrine/metabolic

BioWorld Science, Endocrine/metabolic
RSS

Toa Eiyo presents new agents for diabetes and lipoprotein disorders

Sep. 27, 2002

Effect of BIM-44058 on trabecular microarchitecture in monkey model of postmenopausal osteoporosis

Sep. 27, 2002

Pharmacokinetic data reported for extended-release metformin at recent meeting

Sep. 27, 2002

Advisory committee review of Fabry's disease products delayed

Sep. 27, 2002

New melanocortin agonists in early development at Lilly

Sep. 27, 2002

Androgenic agents discovered at Schering AG

Sep. 26, 2002

New 5-HT2A/5-HT2C modulators for use in obesity, schizophrenia and depression

Sep. 26, 2002

Two rhBMP-2-based products now cleared for marketing

Sep. 26, 2002

Phase I cleared for Islet Neogenesis Therapy

Sep. 25, 2002

Recent patent covers new human PPAR activators discovered at GSK

Sep. 23, 2002

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 25, 2026.
Have brain-computer interfaces finally arrived?
BioWorld
More and more individuals now have chronically implanted brain-computer interface (BCI) systems in their heads. Devices that can record and stimulate neural...
News in brief
BioWorld Asia
BioWorld Asia briefs for June 23, 2026
2026 marks critical turning point for BCI technology
BioWorld
Decades of research are helping unravel the “black box” of the brain. The second article in BioWorld’s series on the Brain-Computer Interface (BCI) field looks at...
Brain-computer interfaces are here but long road ahead
BioWorld
The field of BCI is continually evolving; as such, companies are increasingly highlighting the potential of their technologies to transform care. For advanced...